Европейски съюз - чешки - EMA (European Medicines Agency)

janssen-cilag international n.v.    - ponesimod - roztroušená skleróza, relaps-remitentní - imunosupresiva - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Европейски съюз - чешки - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklidové zobrazování - diagnostické radiofarmaka - tento léčivý přípravek je určen pouze pro diagnostické účely. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Европейски съюз - чешки - EMA (European Medicines Agency)

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresiva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Европейски съюз - чешки - EMA (European Medicines Agency)

janssen-cilag international n.v.   - bosentan (as monohydrate) - scleroderma, systemic; hypertension, pulmonary - antihypertenziva, - léčba plicní arteriální hypertenze (pah) pro zlepšení výkonnosti a symptomů u pacientů s funkční třídou who iii. efficacy has been shown in: , primary (idiopathic and familial) pah;, pah secondary to scleroderma without significant interstitial pulmonary disease;, pah associated with congenital systemic-to-pulmonary shunts and eisenmenger's physiology. některé vylepšení byly také prokázána u pacientů s pah funkční třídy ii. tracleer je též indikován pro snížení počtu nových vředů na prstech u pacientů se systémovou sklerózou a probíhajícím vředovým onemocněním prstů.

Европейски съюз - чешки - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - imunologická vyšetření pro kanyziary - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

potraviny pro zvlÁŠtnÍ lÉkaŘskÉ ÚČely (pzlÚ) (ČeskÁ atc skupina)

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

potraviny pro zvlÁŠtnÍ lÉkaŘskÉ ÚČely (pzlÚ) (ČeskÁ atc skupina)

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

potraviny pro zvlÁŠtnÍ lÉkaŘskÉ ÚČely (pzlÚ) (ČeskÁ atc skupina)

Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

potraviny pro zvlÁŠtnÍ lÉkaŘskÉ ÚČely (pzlÚ) (ČeskÁ atc skupina)

Европейски съюз - чешки - EMA (European Medicines Agency)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika pro systémové použití - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.